Drug Combo Promising in Vascular Cognitive Impairment: LACI-2

A combination of two drugs showed promising phase 2 results, including a reduction in cognitive impairment in patients with lacunar stroke, and may be a potential new approach to small vessel disease.

Related Keywords

New York ,United States ,Cherry Hill ,New Jersey ,Dallas ,Texas ,United Kingdom ,Nottingham ,Edinburgh ,City Of ,Joannam Wardlaw ,Mitchell Elkind ,Tudor Jovin ,Columbia University Irving Medical Center ,International Stroke Conference ,Edinburgh University ,University Of Nottingham ,Cooper Neurological Institute ,Philip Bath ,Medscape Cardiology ,New York City ,Stroke ,Erebrovascular Accident ,Va Cerebrovascular Accident ,Mci ,Mild Cognitive Impairment ,Cognitive Impairment ,Thromboembolism ,Impairment ,Cardiometabolic Risk ,Lacunar Stroke ,Recurrent Stroke ,United Kingdom Site Content ,Uk National Health Service ,United Kingdom National Health Service ,K Nhs ,Dhs ,National Health Service ,Blood ,Blood Vessels ,Atherosclerotic Heart Disease ,Therosclerotic C ,